Arvid Sandforth, MD

Arvid Sandforth, MD, physician scientist, Institute of Diabetes Research and Metabolic Diseases, Tübingen, Germany

Articles by Arvid Sandforth, MD

Timing Matters in Prediabetes Remission, with Arvid Sandforth, MD

July 11th 2025

Sandforth discussed his research that found that early prediabetes remission conferred greater protective effects against T2D than later remission.

HCPLive Five at ADA Scientific Sessions 2025

BySubodh Verma, MD, PhD,Athena Philis-Tsimikas, MD,John Buse, MD, PhD ,Lois Donovan, MD,Denice Feig, MD, MSc,Arvid Sandforth, MD

June 27th 2025

From uncovering new benefits of semaglutide to targeting hypercortisolism in people with type 2 diabetes, here are 5 key updates from the annual meeting.

Glycemic Control Trumps Weight Loss for Type 2 Diabetes Prevention, with Arvid Sandforth, MD

ByArvid Sandforth, MD

June 23rd 2025

Sandforth emphasized the important of achieving prediabetes remission for preventing T2D as seen in his new research.

Arvid Sandforth, MD

Articles by Arvid Sandforth, MD

Timing Matters in Prediabetes Remission, with Arvid Sandforth, MD

HCPLive Five at ADA Scientific Sessions 2025

Glycemic Control Trumps Weight Loss for Type 2 Diabetes Prevention, with Arvid Sandforth, MD

Latest Updated Articles

Trending on HCPLive

Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B

Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial

Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs

What Are the Side Effects of Hair and Skin Supplements in Dermatology? With Rajani Katta, MD

SimpleScreen CRC Blood Test Meets Endpoints in Clinical Validation Study